Skip to main content
. 2021 May 14;11:624057. doi: 10.3389/fonc.2021.624057

Table 2.

Specific characteristics of CCSs group.

CCS group
Age at diagnosis (years ± SD) 6.50 ± 4.39
Years since last anthracycline dose (years ± SD) 6.50 ± 2.74
Cumulative anthracycline dose (mg/m2 ± SD)) 234.50 ± 87.38
Type of malignancies N (%)
Acute lymphoblastic leukemia 8 (40)
Hodgkin lymphoma 3 (15)
Non-Hodgkin lymphoma 3 (15)
Ewing sarcoma 5 (25)
Neuroblastoma 1 (5)